Product
GC203 TIL
1 clinical trial
4 indications
Indication
Advanced Solid TumorIndication
TILIndication
Side EffectsIndication
ImmunotherapyClinical trial
A Study on Tumor Infiltrating Lymphocytes for the Treatment of Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2026-06-30